PAVM - PAVmed Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.88
-0.03 (-1.03%)
As of 10:18AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close2.91
Open3.05
Bid2.86 x 800
Ask2.90 x 100
Day's Range2.87 - 3.06
52 Week Range2.26 - 9.31
Volume2,704
Avg. Volume14,884
Market Cap41.873M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-0.93
Earnings DateNov 30, 2017 - Dec 4, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.05
Trade prices are not sourced from all markets
  • Business Wire13 days ago

    PAVmed Files 510(k) Submission with FDA for CarpX™ Device to Treat Carpal Tunnel Syndrome

    PAVmed Inc. , a highly differentiated, multiproduct medical device company, today announced that it has filed a 510 premarket notification submission with the U.S.

  • What You Must Know About PAVmed Inc’s (PAVM) Major Investors
    Simply Wall St.20 days ago

    What You Must Know About PAVmed Inc’s (PAVM) Major Investors

    In this article, I will take a quick look at PAVmed Inc’s (NASDAQ:PAVM) recent ownership structure – an unconventional investing subject, but an important one. Ownership structure of a companyRead More...

  • ACCESSWIRE25 days ago

    PAVmed to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / November 16, 2017 / PAVmed (NASDAQ: PAVM ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 16, 2017 at 4:30 PM Eastern Time. To listen ...

  • Business Wire26 days ago

    PAVmed Reports Third Quarter 2017 Financial Results

    PAVmed Inc. , a highly differentiated, multiproduct medical device company, today announced financial results for the three and nine months ended September 30, 2017 and provided a business update.

  • Business Wirelast month

    PAVmed Inc. to Hold Business Update Conference Call on November 16th

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on Thursday, November 16, 2017 at 4:30 p.m.

  • Business Wire2 months ago

    PAVmed to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced that Dennis McGrath, PAVmed’s Chief Financial Officer, will present at the Dawson James Securities 3rd Annual Small Cap Growth Conference on Thursday, October 19, 2017 at 1:00 p.m.

  • Business Wire3 months ago

    PAVmed to Present at the Cantor Fitzgerald Global Healthcare Conference

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will present at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2017 at 10:55 a.m.

  • Business Wire4 months ago

    PAVmed Reports Second Quarter 2017 Financial Results

    PAVmed Inc. , a highly differentiated, multiproduct medical device company, today announced financial results for the three and six months ended June 30, 2017 and provided a business update.

  • Business Wire4 months ago

    PAVmed Inc. to Hold Business Update Conference Call on August 17th

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on Thursday, August 17, 2017 at 4:30 p.m.

  • Business Wire5 months ago

    PAVmed Inc. Closes $5 Million Financing

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced the closing of a $5 million financing provided by Scopia Holdings LLC.

  • Business Wire6 months ago

    PAVmed Announces Effectiveness of Form S-1 Resale Registration Statement

    PAVmed Inc. , a highly differentiated, multiproduct medical device company, today announced that on June 23, 2017, the Securities and Exchange Commission declared effective PAVmed’s registration statement on Form S-1 relating to resale by certain selling securityholders of certain shares and warrants issued and issuable from the Company’s previously announced preferred unit offering.

  • Business Wire6 months ago

    PAVmed to Join Russell Microcap® Index

    PAVmed Inc. , a highly differentiated, multiproduct medical device company, today announced that the Company will join the Russell Microcap® Index at the conclusion of the Russell Indexes’ annual reconstitution, effective after the U.S.

  • Business Wire7 months ago

    PAVmed Reports First Quarter 2017 Financial Results and Provides Business Update

    PAVmed Inc. , a highly differentiated, multiproduct medical device company, today announced financial results for the three months ended March 31, 2017 and provided a business update.

  • Business Wire7 months ago

    PAVmed Inc. Postpones Business Update Conference Call to May 31st

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced that the Company will postpone its business update conference call to May 31, 2017 at 4:30 p.m.

  • Business Wire7 months ago

    PAVmed Inc. to Hold Business Update Conference Call on May 17th

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on May 17, 2017 at 4:30 p.m.

  • Business Wire8 months ago

    PAVmed Announces Filing of Exchange Offer Registration Statement with the SEC

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced that it filed a registration statement on Form S-4 with the Securities and Exchange Commission relating to the Company’s previously announced intention to effectuate a registered exchange offer whereby PAVmed’s Common Stock will become exchangeable for units .

  • Business Wire8 months ago

    PAVmed Announces Revised Presentation Time at the 16th Annual Needham Healthcare Conference

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced a revised time for the Company’s presentation at the 16th Annual Needham Healthcare Conference.

  • Business Wire8 months ago

    PAVmed to Present at the 16th Annual Needham Healthcare Conference

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will present at the 16th Annual Needham Healthcare Conference on Wednesday, April 5, 2017, at 10:20 a.m.

  • Business Wire8 months ago

    PAVmed Announces Filing of Registration Statement Relating to Private Placement

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced that the Company has filed a registration statement on Form S-1 with the Securities and Exchange Commission for the securities underlying the units sold in the Company’s private placement previously announced on February 2, 2017.

  • Business Wire9 months ago

    PAVmed Names Medical Device Industry Veteran Dennis M. McGrath as Chief Financial Officer

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced that it has appointed Dennis M. McGrath as its new Executive Vice President and Chief Financial Officer.

  • Business Wire9 months ago

    PAVmed Announces Closing of Additional Financing

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced the closing of approximately $1.0 million in additional financing, bringing the aggregate gross proceeds of our private placement to $2.5 million.

  • Business Wire10 months ago

    PAVmed Announces Exchange Offer

    PAVmed Inc. announced today that the Company intends to effectuate a registered exchange offer whereby PAVmed’s Common Stock will become exchangeable for units .

  • Business Wire10 months ago

    PAVmed to Hold Business Update Conference Call and Webcast on February 22nd

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced financial results for the fourth quarter and year ended December 31, 2016, and that the Company will host a business update conference call on February 22, 2017 at 4:30 p.m.

  • Business Wire10 months ago

    PAVmed Announces Warrants Now Exercisable for Cash

    PAVmed Inc. , a highly differentiated, multi-product medical device company, announced that at 4:00 pm today the Securities and Exchange Commission declared effective the company’s registration statement relating to shares of common stock underlying the warrants included in the units issued in the company’s IPO and certain other warrants .

  • Business Wire10 months ago

    PAVmed Inc. Announces Closing of Financing

    PAVmed Inc. , a highly differentiated, multi-product medical device company, today announced the closing of a $1.5 million financing. The private placement consists of shares of Series A Convertible Preferred Stock and Series A Warrants .